{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T23:07:39Z","timestamp":1765235259031,"version":"3.46.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"S6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW Fortschr Med"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s15006-025-5435-0","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T23:02:44Z","timestamp":1765234964000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eisenmangel bei Herzinsuffizienz","Iron deficiency in heart failure \u2013 a practical guide for diagnosis and therapy"],"prefix":"10.1007","volume":"167","author":[{"given":"Gunnar","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Flierl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Rybak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"5435_CR2319","unstructured":"Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in der Bundesrepublik Deutschland (Zi) Stiftung des b\u00fcrgerlichen Rechts, Berlin. https:\/\/www.versorgungsatlas.de\/dashboard (Abfrage am 28. M\u00e4rz 2025)"},{"key":"5435_CR2323","unstructured":"Deutsche Herzstiftung (Hrsg). 35. Deutscher Herzbericht (Update 2024). https:\/\/herzstiftung.de\/herzbericht (Abfrage am 28. M\u00e4rz 2025)"},{"key":"5435_CR2327","doi-asserted-by":"crossref","unstructured":"Doehner W et al. Eisenmangel bei Patienten mit chronischer Herzinsuffizienz \u2013 diagnostische Algorithmen und therapeutische Optionen anhand der aktuellen Studienlage. Dtsch Med Wochenschr. 2017;142(10):752\u20137","DOI":"10.1055\/s-0043-100900"},{"key":"5435_CR2331","doi-asserted-by":"crossref","unstructured":"Ebner N et al. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure. Int J Cardiol. 2016;205:6\u201312","DOI":"10.1016\/j.ijcard.2015.11.178"},{"key":"5435_CR2335","doi-asserted-by":"crossref","unstructured":"Anker S et al. FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436\u201348","DOI":"10.1056\/NEJMoa0908355"},{"key":"5435_CR2339","doi-asserted-by":"crossref","unstructured":"Jankowska EA et al. The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. Eur Heart J. 2021;42(31):3011\u201320","DOI":"10.1093\/eurheartj\/ehab234"},{"key":"5435_CR2343","doi-asserted-by":"crossref","unstructured":"Kalra PR et al; IRONMAN Study Group. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet 2022;400(10369):2199\u20132209","DOI":"10.1016\/S0140-6736(22)02083-9"},{"key":"5435_CR2347","doi-asserted-by":"crossref","unstructured":"Anker SD et al. Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial. JAMA. 2025;333(22):1965\u201376","DOI":"10.1001\/jama.2025.3833"},{"key":"5435_CR2265","doi-asserted-by":"crossref","unstructured":"Anker SD et al. Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency. Nat Med. 2025;31(8):2640\u20136","DOI":"10.1038\/s41591-025-03671-1"},{"key":"5435_CR2353","doi-asserted-by":"crossref","unstructured":"McDonagh TA et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u20133726","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"5435_CR2357","doi-asserted-by":"crossref","unstructured":"McDonagh TA et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627\u201339","DOI":"10.1093\/eurheartj\/ehad195"},{"key":"5435_CR2365","doi-asserted-by":"crossref","unstructured":"Packer M. Iron homeostasis, recycling and vulnerability in the stressed kidney: A neglected dimension of iron-deficient heart failure. Eur J Heart Fail. 2024;26(7):1631\u201341","DOI":"10.1002\/ejhf.3238"},{"key":"5435_CR2369","doi-asserted-by":"crossref","unstructured":"Packer M et al. Redefining iron deficiency in patients with chronic heart failure. Circulation. 2024;150(2):151\u201361","DOI":"10.1161\/CIRCULATIONAHA.124.068883"},{"key":"5435_CR2375","doi-asserted-by":"crossref","unstructured":"Lewis GD et al; NHLBI Heart Failure Clinical Research Network. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA. 2017;317(19):1958\u201366","DOI":"10.1001\/jama.2017.5427"},{"key":"5435_CR2379","unstructured":"S3-Leitlinie Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz. Langfassung \u2013 Version 4.0. AWMF Reg.-Nr. nvl-006; https:\/\/register.awmf.org\/de\/leitlinien\/detail\/nvl-006"},{"key":"5435_CR2383","unstructured":"Fachinformation MonoFer 100 mg\/ml L\u00f6sung. Stand Juli 2023"},{"key":"5435_CR2387","unstructured":"Fachinformation Ferinject 50 mg Eisen\/ml. Stand September 2024"},{"key":"5435_CR2391","doi-asserted-by":"crossref","unstructured":"Macdougall IC et al. Intravenous iron in patients undergoing maintenance hemodialysis. N Engl J Med. 2019; 380(5):447\u201358","DOI":"10.1056\/NEJMoa1810742"},{"key":"5435_CR2271","doi-asserted-by":"crossref","unstructured":"Evstatiev R et al; FERGI Study Group. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141(3):846\u201353","DOI":"10.1053\/j.gastro.2011.06.005"},{"key":"5435_CR2410","doi-asserted-by":"crossref","unstructured":"Lim W et al. Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults. Vox Sang. 2019;114(4):363\u201373","DOI":"10.1111\/vox.12773"},{"key":"5435_CR2415","doi-asserted-by":"crossref","unstructured":"Charles-Edwards G et al. Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency. Circulation 2019; 139(21):2386-98","DOI":"10.1161\/CIRCULATIONAHA.118.038516"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-025-5435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15006-025-5435-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-025-5435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T23:02:48Z","timestamp":1765234968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-025-5435-0"}},"subtitle":["Ein praxisnaher Leitfaden f\u00fcr Diagnostik und Therapie"],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":21,"journal-issue":{"issue":"S6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5435"],"URL":"https:\/\/doi.org\/10.1007\/s15006-025-5435-0","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"9 December 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gunnar Klein hat Honorare f\u00fcr Beratert\u00e4tigkeiten von Biotronik und Pharmacosmos und Vortragshonorare von AMGEN, Astra-Zeneca, Bayer Healthcare, BMS, Boehringer Ingelheim, Boston Scientific, Daichi-Sankyo, Medtronic, Novartis, Pfizer erhalten. Ulrike Flierl hat Honorare f\u00fcr Beratert\u00e4tigkeiten bei Pharmacosmos erhalten. Karin Rybak hat Honorare f\u00fcr Beratert\u00e4tigkeiten von Pharmacosmos erhalten.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Der Beitrag wurde im Rahmen eines wissenschaftlichen Symposiums finanziell unterst\u00fctzt durch Pharmacosmos GmbH, Wiesbaden.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}